{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:08:48Z","timestamp":1773061728982,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ajps.2024.100892","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T16:48:56Z","timestamp":1709138936000},"page":"100892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A natural compound-empowered podophyllotoxin prodrug nanoassembly magnifies efficacy-toxicity benefits in cancer chemotherapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Ziqi","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuequan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-9598","authenticated-orcid":false,"given":"Cong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajps.2024.100892_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.ajps.2024.100892_bib0002","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.ajps.2024.100892_bib0003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.nantod.2017.06.008","article-title":"Evolution and clinical translation of drug delivery nanomaterials","volume":"15","author":"Hassan","year":"2017","journal-title":"Nano Today"},{"issue":"7","key":"10.1016\/j.ajps.2024.100892_bib0004","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41576-019-0114-6","article-title":"Resolving genetic heterogeneity in cancer","volume":"20","author":"Turajlic","year":"2019","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.ajps.2024.100892_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15212\/AMM-2022-1001","article-title":"Drug discovery is an eternal challenge for the biomedical sciences","volume":"1","author":"Li","year":"2022","journal-title":"Acta Materia Medica"},{"issue":"46","key":"10.1016\/j.ajps.2024.100892_bib0006","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1002\/smll.201601597","article-title":"Facile fabrication of tumor redox-sensitive nanoassemblies of small-molecule oleate prodrug as potent chemotherapeutic nanomedicine","volume":"12","author":"Luo","year":"2016","journal-title":"Small"},{"issue":"8","key":"10.1016\/j.ajps.2024.100892_bib0007","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41589-020-0596-8","article-title":"Chemical strategies to overcome resistance against targeted anticancer therapeutics","volume":"16","author":"Pisa","year":"2020","journal-title":"Nat Chem Biol"},{"issue":"11","key":"10.1016\/j.ajps.2024.100892_bib0008","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ajps.2024.100892_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2022.135160","article-title":"Emerging small molecule-engineered hybrid nanomedicines for cancer therapy","volume":"435","author":"Chen","year":"2022","journal-title":"Chem Eng J"},{"issue":"12","key":"10.1016\/j.ajps.2024.100892_bib0010","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3390\/pharmaceutics15122728","article-title":"Podophyllotoxin: recent advances in the development of hybridization strategies to enhance its antitumoral profile","volume":"15","author":"Miranda-Vera","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2024.100892_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115039","article-title":"Advances of podophyllotoxin and its derivatives: patterns and mechanisms","volume":"200","author":"Shi","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.ajps.2024.100892_bib0012","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/biom11040603","article-title":"Podophyllotoxin: history, recent advances and future prospects","volume":"11","author":"Shah","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajps.2024.100892_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1191498","article-title":"Synthesis and anticancer activity of podophyllotoxin derivatives with nitrogen-containing heterocycles","volume":"11","author":"Yin","year":"2023","journal-title":"Front Chem"},{"issue":"3","key":"10.1016\/j.ajps.2024.100892_bib0014","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1039\/D0NP00041H","article-title":"Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy","volume":"38","author":"Zhao","year":"2021","journal-title":"Nat Prod Rep"},{"issue":"1","key":"10.1016\/j.ajps.2024.100892_bib0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/molecules28010302","article-title":"Chemistry and biological activities of naturally occurring and structurally modified podophyllotoxins","volume":"28","author":"Jin","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ajps.2024.100892_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112830","article-title":"Recent advances of podophyllotoxin\/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: an update (2010-2020)","volume":"208","author":"Xiao","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"8","key":"10.1016\/j.ajps.2024.100892_bib0017","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.trecan.2020.05.001","article-title":"Nanotherapeutics for antimetastatic treatment","volume":"6","author":"Yang","year":"2020","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.ajps.2024.100892_bib0018","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41467-023-36334-1","article-title":"Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy","volume":"14","author":"Linares","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajps.2024.100892_bib0019","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jconrel.2020.07.036","article-title":"Dimeric prodrug-based nanomedicines for cancer therapy","volume":"326","author":"Li","year":"2020","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.ajps.2024.100892_bib0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ajps.2021.02.001","article-title":"Investigating the crucial roles of aliphatic tails in disulfide bond-linked docetaxel prodrug nanoassemblies","volume":"16","author":"Wang","year":"2021","journal-title":"Asian J Pharm Sci"},{"issue":"41","key":"10.1016\/j.ajps.2024.100892_bib0021","doi-asserted-by":"crossref","first-page":"16680","DOI":"10.1021\/ja207463b","article-title":"Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy","volume":"133","author":"Santra","year":"2011","journal-title":"J Am Chem Soc"},{"issue":"52","key":"10.1016\/j.ajps.2024.100892_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202101460","article-title":"Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery","volume":"17","author":"Li","year":"2021","journal-title":"Small"},{"issue":"9","key":"10.1016\/j.ajps.2024.100892_bib0023","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1021\/acs.nanolett.6b01632","article-title":"Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy","volume":"16","author":"Luo","year":"2016","journal-title":"Nano Lett"},{"issue":"6","key":"10.1016\/j.ajps.2024.100892_bib0024","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.cclet.2020.02.036","article-title":"Advances in aggregatable nanoparticles for tumor-targeted drug delivery","volume":"31","author":"Yu","year":"2020","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.ajps.2024.100892_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2019.04.001","article-title":"Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy","volume":"302","author":"Luo","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.ajps.2024.100892_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmatsci.2023.101070","article-title":"Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer","volume":"134","author":"Kong","year":"2023","journal-title":"Prog Mater Sci"},{"issue":"9","key":"10.1016\/j.ajps.2024.100892_bib0027","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.trechm.2023.05.006","article-title":"Bioorthogonal chemistry-driven anticancer nanotherapeutics","volume":"5","author":"Zhang","year":"2023","journal-title":"Trends Chem"},{"issue":"11","key":"10.1016\/j.ajps.2024.100892_bib0028","doi-asserted-by":"crossref","first-page":"16974","DOI":"10.1021\/acsnano.1c09139","article-title":"Nanoparticles for cancer diagnosis, radionuclide therapy and theranostics","volume":"15","author":"Llop","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ajps.2024.100892_bib0029","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tips.2017.10.009","article-title":"Remodeling the tumor microenvironment with emerging nanotherapeutics","volume":"39","author":"Chen","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.ajps.2024.100892_bib0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ajps.2022.02.004","article-title":"Elaborately engineering of a dual-drug co-assembled nanomedicine for boosting immunogenic cell death and enhancing triple negative breast cancer treatment","volume":"17","author":"Wang","year":"2022","journal-title":"Asian J Pharm Sci"},{"issue":"9","key":"10.1016\/j.ajps.2024.100892_bib0031","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.ajps.2024.100892_bib0032","article-title":"Self-adaptive nanoassembly enabling turn-on hypoxia illumination and periphery\/center closed-loop tumor eradication","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep Med"},{"issue":"12","key":"10.1016\/j.ajps.2024.100892_bib0033","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.cclet.2020.05.034","article-title":"Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models","volume":"31","author":"He","year":"2020","journal-title":"Chin Chem Lett"},{"issue":"5","key":"10.1016\/j.ajps.2024.100892_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201701070","article-title":"Sequentially triggered nanoparticles with tumor penetration and intelligent drug release for pancreatic cancer therapy","volume":"5","author":"He","year":"2018","journal-title":"Adv Sci"},{"issue":"1","key":"10.1016\/j.ajps.2024.100892_bib0035","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/pharmaceutics15010262","article-title":"Reduction-responsive stearyl alcohol-cabazitaxel prodrug nanoassemblies for cancer chemotherapy","volume":"15","author":"Liu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ajps.2024.100892_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120737","article-title":"Smart transformable nanomedicines for cancer therapy","volume":"271","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.ajps.2024.100892_bib0037","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.cclet.2021.11.056","article-title":"Precisely engineering a dual-drug cooperative nanoassembly for proteasome inhibition-potentiated photodynamic therapy","volume":"33","author":"Yang","year":"2022","journal-title":"Chin Chem Lett"},{"issue":"3","key":"10.1016\/j.ajps.2024.100892_bib0038","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajps.2020.07.003","article-title":"Recent advances of sorafenib nanoformulations for cancer therapy: smart nanosystem and combination therapy","volume":"16","author":"Chen","year":"2021","journal-title":"Asian J Pharm Sci"},{"issue":"3","key":"10.1016\/j.ajps.2024.100892_bib0039","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/pharmaceutics15030784","article-title":"Reduction-hypersensitive podophyllotoxin prodrug self-assembled nanoparticles for cancer treatment","volume":"15","author":"Wang","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ajps.2024.100892_bib0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajps.2022.02.002","article-title":"Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy","volume":"17","author":"Li","year":"2022","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"10.1016\/j.ajps.2024.100892_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188569","article-title":"Targeting Bcl-2 for cancer therapy","volume":"1876","author":"Zhang","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"10.1016\/j.ajps.2024.100892_bib0042","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13020-023-00869-8","article-title":"The potential roles of gossypol as anticancer agent: advances and future directions","volume":"18","author":"Paunovic","year":"2023","journal-title":"Chin Med"},{"issue":"12","key":"10.1016\/j.ajps.2024.100892_bib0043","doi-asserted-by":"crossref","first-page":"e50786","DOI":"10.1371\/journal.pone.0050786","article-title":"Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"issue":"34","key":"10.1016\/j.ajps.2024.100892_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202300104","article-title":"Cobalt ferrite-gossypol coordination nanoagents with high photothermal conversion efficiency sensitizing chemotherapy against Bcl-2 to induce tumor apoptosis","volume":"19","author":"Zeng","year":"2023","journal-title":"Small"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087624000096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087624000096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T16:13:51Z","timestamp":1725552831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087624000096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1818087624000096"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2024.100892","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A natural compound-empowered podophyllotoxin prodrug nanoassembly magnifies efficacy-toxicity benefits in cancer chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2024.100892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of Shenyang Pharmaceutical University.","name":"copyright","label":"Copyright"}],"article-number":"100892"}}